| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Basilea Pharmaceutica AG (SW: BSLN)
BSLN Technical Analysis
5
| As on 9th May 2025 BSLN STOCK Price closed @ 44.40 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 39.62 & Strong Buy for SHORT-TERM with Stoploss of 34.91 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BSLNSTOCK Price
| Open | 44.45 | Change | Price | % |
| High | 44.80 | 1 Day | 0.15 | 0.34 |
| Low | 43.80 | 1 Week | 0.70 | 1.60 |
| Close | 44.40 | 1 Month | -2.45 | -5.23 |
| Volume | 35514 | 1 Year | 8.70 | 24.37 |
| 52 Week High 48.55 | 52 Week Low 32.25 | ||||
SW Switzerland Most Active Stocks
| CSGN | 0.82 | 0.00% |
| CSGN | 0.82 | 0.00% |
| UBSG | 25.96 | 0.74% |
| UBSG | 25.96 | 0.74% |
| NOVN | 90.91 | -0.22% |
| NOVN | 90.91 | -0.22% |
| PRFN | 0.03 | 50.00% |
| NESN | 87.65 | 0.68% |
| NESN | 87.65 | 0.68% |
| ABBN | 45.07 | 0.04% |
SW Switzerland Top Gainers Stocks
SW Switzerland Top Losers Stocks
| BSLN Daily Charts |
BSLN Intraday Charts |
Whats New @ Bazaartrend |
BSLN Free Analysis |
|
|
BSLN Important Levels Intraday
| RESISTANCE | 46.33 |
| RESISTANCE | 45.71 |
| RESISTANCE | 45.33 |
| RESISTANCE | 44.95 |
| SUPPORT | 43.86 |
| SUPPORT | 43.47 |
| SUPPORT | 43.09 |
| SUPPORT | 42.47 |
BSLN Forecast May 2025
| 4th UP Forecast | 51.63 |
| 3rd UP Forecast | 49.31 |
| 2nd UP Forecast | 47.88 |
| 1st UP Forecast | 46.44 |
| 1st DOWN Forecast | 42.36 |
| 2nd DOWN Forecast | 40.92 |
| 3rd DOWN Forecast | 39.49 |
| 4th DOWN Forecast | 37.17 |
BSLN Weekly Forecast
| 4th UP Forecast | 48.64 |
| 3rd UP Forecast | 47.28 |
| 2nd UP Forecast | 46.44 |
| 1st UP Forecast | 45.60 |
| 1st DOWN Forecast | 43.20 |
| 2nd DOWN Forecast | 42.36 |
| 3rd DOWN Forecast | 41.52 |
| 4th DOWN Forecast | 40.16 |
BSLN Forecast2025
| 4th UP Forecast | 76.68 |
| 3rd UP Forecast | 66.33 |
| 2nd UP Forecast | 59.93 |
| 1st UP Forecast | 53.53 |
| 1st DOWN Forecast | 35.27 |
| 2nd DOWN Forecast | 28.87 |
| 3rd DOWN Forecast | 22.47 |
| 4th DOWN Forecast | 12.12 |
Basilea Pharmaceutica AG ( SW Switzerland Symbol : BSLN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BSLN Business Profile
Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. It offers Cresemba, an intravenous and oral azole antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, the European Union, and internationally, as well as in Phase III clinical trials for invasive fungal infections in Japan. The company also provides Zevtera, an antibiotic for the treatment of community and hospital-acquired pneumonia, as well as in Phase III clinical trials for the treatment of acute bacterial skin and skin structure infections, and Staphylococcus aureus bacteremia in European and various non-European countries. In addition, it engages in developing Derazantinib, a small molecule inhibitor, which is in phase 2 clinical trial for bile duct cancer, as well as in phase ½ clinical trial for bladder and stomach cancer; and Lisavanbulin, a tumor checkpoint controller drug. The company was founded in 2000 and is headquartered in Basel, Switzerland. Address: Grenzacherstrasse 487, Basel, Switzerland, 4058
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service